Novozymes delivered solid earnings and double-digit organic sales growth in both the first half and in the second quarter. Despite the volatile market environment, the company narrows its full-year organic sales outlook upwards from 4-8% to now 6-8% and raises EBIT-margin expectations from 25-26% to now 26-27%.

COPENHAGEN, Denmark – August 11, 2022. Novozymes delivers 10% organic sales growth and an EBIT-margin of 26% in the first half of the year, with 18% organic sales growth in DKK. Good momentum and strong half year and Q2 results have led to a narrowed full-year organic sales growth outlook to 6-8%.

“We deliver strong results for the first half of 2022 and growth is broad-based across the business. In fact, we deliver double-digit organic sales growth in four out of five business areas and in both developing and emerging markets. Our well-diversified portfolio and operational excellence prove the value our solutions generate to our customers. We are executing very well across our portfolio and markets, and in line with our strategic direction,” says Ester Baiget, President & CEO, and continues:

“Following a strong first half of the year we narrow our full-year outlook upwards to 6-8% organic sales growth, and we continue to expect solid margins and returns despite the significant pressure from input and logistic costs. This is a clear testament that our positioning and product portfolio is strong, and that we are able to drive our strategy forward balancing short-term execution with a clear long-term focus. We are ready to show the world the power of biotech.”

During the first half of the 2022 financial year, Novozymes has launched six new products. Four are launched in the second quarter covering efficient yeast solutions in Bioenergy, growth stimulators for broad acre crops in agriculture, and a solution for soap bars in Household Care for the emerging markets, allowing for longer storage times without losing efficacy.

Business area results For the first half of the 2022 financial year, organic performance by business area were 0% (4% in Q2) in Household Care, 10% (3% in Q2) in Food, Beverages & Human Health, 23% (19% in Q2) in Bioenergy, 13% (17% in Q2) in Grain & Tech Processing, and 14% (17% in Q2) in Agriculture, Animal Health & Nutrition.

Sales in Household Care in both the first half of the year and in Q2 was driven by solid performance in Emerging Markets. Sales in Q2 was negatively impacted by the war in Ukraine. Overall, the performance was in line with expectations.

For the first half of the 2022 financial year, organic growth rates by geography were 7% (3% in Q2) in Europe, Middle East & Africa, 12% (14% in Q2) in North America, 9% (13% in Q2) in Asia Pacific, and 19% (23% in Q2) in Latin America. Sales in emerging markets grew 10% (12% in Q2) organically and developed markets grew 10% (9% in Q2) organically.

Financial outlook for 2022 Novozymes has delivered solid first-half performance of 10% organic sales growth and narrows its full-year outlook range from 4-8% to now 6-8%. This includes the previously mentioned negative full-year impact of around 1% from the Ukraine war, mainly impacting Household Care.

Novozymes is experiencing good momentum across a large part of its portfolio with the focus on innovations and market penetration combined with supportive market conditions. Sales in DKK are expected to be around 8% higher than the organic sales growth outlook.

As events after the interim period - Novozymes signed an agreement to invest intellectual property in 21st.BIO, expected to be completed in the third quarter of 2022. As an effect of the accounting gain the company now expects a solid EBIT-margin of 26-27%, raised from 25-26%. ROIC including goodwill is now expected at 17-18% instead of 16%-17%. The accounting gain is of a non-cash character. Additionally, following the announced sale of Albumedix, Novozymes will as part of the agreement divest its 8% ownership in Albumedix, a company built with Novozymes’ technology platform. The acquisition is subject to customary closing conditions and is expected to close during the second half of the year. Upon closing, the sale will lead to a tax-exempt financial gain and cash flow of around DKK 250 million.

About Novozymes Novozymes is the world leader in biological solutions. Together with customers, partners, and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel, and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com NASDAQ OMX: NZYM-B • 6,500 employees • DKK 15 billion turnover • 30+ industries • 700+ products

Lina Danstrup, Head of Media Relations Phone: +45 30 77 05 52 lind@novozymes.com

Tobias Cornelius Björklund Head of Investor Relations Phone: +45 30 77 86 82 tobb@novozymes.com

Because you don’t have to wait until winter to try and trim back. By Vicky Shaw.

Some 23% of firms with more than 10 employees reported a rise in hourly wages.

The mobile operator has revealed crowd movement data from its network shows people are returning to the office in London, but only on certain days.

So-called "side pockets", used by hedge funds in the global financial crisis, but previously not allowed for mainstream European funds, separate out illiquid often risky assets so main funds can trade freely and attract new investors who would not share in any gains or losses from those assets. Schroders last month set up side pockets for Russian assets in its Luxembourg-domiciled emerging Europe fund, which has total assets of more than 200 million euros ($207 million), the company said. Austria's Erste told Reuters it was considering a similar move for Russian assets in its suspended emerging Europe fund.

Global Oncology Drugs Market Global Oncology Drugs Market Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Oncology Drugs Market (2022-2027) by Drug Class, Indication, End-user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Oncology Drugs Market is estimated to be USD 156.49 Bn in 2022 and is expected to reach USD 224.35 Bn by 2027, growing at a CAGR of 7.47%.Market Segmentations The Gl

Supervisory board of AS Harju Elekter elected Mr Priit Treial as the new member of the board and chief financial officer of the company, taking office on 14 November 2022 and his term of office is three years. Priit Treial has been a member of the board and chief financial officer of Elektrilevi OÜ since 2018, and a member of the council of Narva Soojus AS and Imatra Elekter AS since 2021. In 2016-2018, he worked as a financial controller at Eesti Energia AS. In addition, he has long-term work e

Ethiopia kickstarted electricity production from the second turbine at its controversial mega-dam on the Blue Nile on Thursday, despite continuing objections by Egypt and Sudan over the project.

Families are being squeezed on all sides by surging mortgage, energy and food costs. Free products and services have rarely been so valuable in keeping household budgets under control – yet they are disappearing quickly.

CWU’s Andy Furey says issues at stake ‘are all remarkably similar’ across separate trade disputes

Biopharmaceutical companies rely on contract manufacturing organizations (CMOs) to provide capabilities and skills as needed. The CMO has provided most of the company’s production in some cases.New York, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biopharmaceutical Contract Manufacturing Market – Global Outlook & Forecast 2022-2027" - https://www.reportlinker.com/p06313593/?utm_source=GNW The market is mainly growing owing to the uptake of branded biol

Winter sun holidays from Wales have been scuppered as Wizz Air cancels flights to beach destinations from Cardiff airport.

The Public and Commercial Services Union has said the Scottish Government’s pay offer is a ‘real terms pay cut’.

The ultimate “DAO operating system” solution for DAO creation and management, The Summon Platform, shows strong momentum since announcement three weeks ago. Next week, the platform’s crucial utility/governance token will be distributed to community members encouraging their active participation in development priorities.ZUG, Switzerland, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The Summon Platform, a comprehensive “operating system” for groups and organizations to easily create and manage Decentralized

Global Hearth Market Global Hearth Market Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Hearth Market by Fuel Type (Wood, Electricity, Gas, Pellet), Product (Fireplaces, Inserts, Stoves), Placement, Design, Application, Fireplace Type, Vent Availability, Ignition Type, Material and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The global hearth market was valued at USD 9.3 billion in 2021 and is projected to reach USD 14.8 billion by 2027, registe

Global Carbon Fiber Bike Market Global Carbon Fiber Bike Market Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Carbon Fiber Bike Market Research Report by Type (Mountain Bikes and Road Bikes), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering. The Global Carbon Fiber Bike Market size was estimated at USD 2,803.27 million in 2021, USD 3,017.47 million

Explainer: The looming hardship is fuelling support for Don’t Pay UK campaign, but there are other approaches

The Leicester-headquartered company reported its revenue grew 13.7% to £27.7 million in the four months to July 31.

As thousands plan to cancel direct debits in protest at soaring energy prices, charities warn about dangerous levels of debt

Top culture and dining gets city 85% approval rating; Aberdeen comes last and London rated seventh

Plastic Decking Market Research Report by Resin Type (High-Density Polyethylene, Low-Density Polyethylene, and Other Resins in Plastic Decking Market), Composite Type, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19New York, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Plastic Decking Market Research Report by Resin Type, Composite Type, End User, Region - Global Forec